Aquestive Therapeutics Inc.
News
Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th
Globe Newswire WARREN, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ( Aquestive or the Company ), a pharmaceutical company advancing medicines to bring meaningful...\n more…
Market Participants Recognise Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Revenues Pushing Shares 27% Higher
Simply Wall St Aquestive Therapeutics, Inc. ( NASDAQ:AQST ) shares have continued their recent momentum with a 27% gain in the last...\n more…
Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings
SeekingAlpha Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings...\n more…
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Globe Newswire WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ( Aquestive or the Company ), a pharmaceutical company advancing medicines to bring meaningful...\n more…
Aquestive Therapeutics: Robust Development Of Oral Emergency Therapies Will Likely Pay Off Into 2025
SeekingAlpha Aquestive Therapeutics: Robust Development Of Oral Emergency Therapies Will Likely Pay Off Into 2025...\n more…
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Given Average Rating of "Buy" by Analysts
Ticker Report Aquestive Therapeutics, Inc. (NASDAQ:AQST - Get Free Report) has received a consensus rating of "Buy" from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Six...\n more…